GTR Test Accession:
Help
GTR000508975.4
CAP
Last updated in GTR:
2022-09-27
View version history
GTR000508975.4,
last updated:
2022-09-27
GTR000508975.3,
last updated:
2021-10-02
GTR000508975.2,
last updated:
2020-09-29
GTR000508975.1,
registered in GTR:
2019-10-08
Last annual review date for the lab: 2024-08-30
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Pre-symptomatic
Conditions (1):
Help
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
Genes (1):
Help
NOTCH3 (19p13.12)
Methods (1):
Help
Molecular Genetics - Sequence analysis of select exons: Bi-directional Sanger Sequence Analysis
Target population: Help
Not provided
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Specimen Source:
Help
- Amniocytes
- Amniotic fluid
- Bone marrow
- Chorionic villi
- Cord blood
- Fetal blood
- Fresh tissue
- Frozen tissue
- Isolated DNA
- Peripheral (whole) blood
- Product of conception (POC)
Lab contact:
Help
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
Currently, samples are only accepted from residents of Canada. Please use the General Requisition form on our website.
Order URL
Order URL
Informed consent required:
Help
Decline to answer
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Test Order Code,
Test strategy,
Test development
Conditions
Help
Total conditions: 1
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 1
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Sequence analysis of select exons
Bi-directional Sanger Sequence Analysis
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis;
Pre-symptomatic
Recommended fields not provided:
Clinical validity,
Clinical utility,
Target population,
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Comments:
Help
Pre-symptomatic testing will only be performed following genetic counselling by a recognized genetic service.
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
NOTCH3 mutations are identified in greater than 90% of individuals with the clinical and radiographic diagnosis of CADASIL, and approximately 90% of all mutations identified to date are located in NOTCH3 exons 2 - 6. The overall clinical sensitivity of this assay, therefore, is approximately 80% in cases of otherwise …
View more
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
Not Applicable
Additional Information
Clinical resources:
Molecular resources:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.